Skip to main content

Table 2 Antimicrobial activity (MIC = µM/ml) of the synthesized analogous

From: Design, synthesis and biological potentials of novel tetrahydroimidazo[1,2-a]pyrimidine derivatives

Comp.

Minimum inhibitory concentration (MIC)

Bacterial strains

Fungal strains

S. aureus

B. subtilis

E. coli

C. albicans

A. niger

1

2.19

2.19

2.19

2.19

1.09

2

4.19

2.10

2.10

1.05

1.05

3

2.27

2.27

2.27

1.13

1.13

4

4.33

4.33

8.67

2.17

1.08

5

9.07

1.13

9.07

2.27

1.13

6

2.27

2.27

2.27

2.27

1.13

7

2.28

1.14

2.28

2.28

1.14

8

2.39

2.39

2.39

2.39

1.20

9

2.26

2.26

2.26

2.26

1.13

10

2.18

2.18

2.18

2.18

1.09

11

2.33

1.17

2.33

2.33

1.17

12

2.14

2.14

2.14

2.14

2.14

13

9.33

2.33

9.33

2.33

2.33

14

2.14

2.14

2.14

2.14

2.14

15

4.16

1.04

2.08

1.04

1.04

16

4.66

1.17

2.33

2.33

2.33

17

2.34

1.17

2.34

2.34

1.17

18

4.63

0.58

2.31

2.31

2.31

19

2.47

1.24

2.47

2.47

1.24

20

2.31

1.16

2.31

1.16

2.31

21

2.21

1.10

1.10

1.10

1.10

22

2.39

2.39

2.39

1.20

1.20

23

4.63

1.16

2.31

2.31

2.31

24

2.35

1.17

2.35

1.17

1.17

Std.

0.47a

0.47a

0.47a

0.50b

0.50b

  1. aNorfloxacin
  2. bFluconazole